SLNO

SLNO Stock-Based Compensation

$21.17MTTM · USD

Period ending:

SLNO FY Stock-Based CompUSD
SLNO FY Stock-Based Comp2012-12-31: $24.42K2013-12-31: $38.42K2014-12-31: $345.44K2015-12-31: $942.37K2016-12-31: $871.27K2017-12-31: $880.03K2018-12-31: $988.00K2019-12-31: $825.00K2020-12-31: $1.50M2021-12-31: $3.28M2022-12-31: $2.53M2023-12-31: $5.95M2024-12-31: $99.96M2025-12-31: $45.85M$99.96M$0.00
2012-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

SLNO stock-based compensation history

Non-cash compensation expense paid in equity. The available annual fiscal periods series contains 14 observations from Dec 31, 2012 to Dec 31, 2025.

Soleno Therapeutics Inc Stock-Based Compensation — Annual fiscal periods (USD)
Period endingStock-Based Compensation (USD)
45,846,000
99,958,000
5,945,000
2,530,000
3,276,000
1,500,000
825,000
988,000
880,031
871,270
942,369
345,435
38,417
24,415

Compare stock-based compensation

All SLNO financial metrics · SLNO stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.